SKOPE-Study of Ketorolac vs Opioid for Pain after Endoscopy: A Double-Blinded Randomized Control Trial in Patients Undergoing Ureteroscopy.

Author: DeSmita, EliaMarlie, FarisAnna, FedrigonDonald, JainRajat, KachrooNaveen, LiJianbo, MongaManoj, NobleMark, SivalingamSri, WilkinsLamont

Paper Details 
Original Abstract of the Article :
Pain is the leading cause of unplanned emergency department visits and readmissions after ureteroscopy, making postoperative analgesic stewardship a priority given the current opioid epidemic. We conducted a double-blinded, randomized controlled trial, with noninferiority design, comparing nonsteroi...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1097/JU.0000000000001772

データ提供:米国国立医学図書館(NLM)

Easing the Pain: A Comparative Study of Ketorolac vs. Opioids After Ureteroscopy

The pain of a medical procedure can be a daunting obstacle, like a scorching sun beating down on a weary traveler. This study, like a cool oasis in the desert, explores alternative pain management strategies for patients undergoing ureteroscopy, a procedure used to treat kidney stones. The researchers employed a double-blinded, randomized controlled trial, a meticulous approach like a caravan carefully mapping its route, to compare the efficacy of ketorolac, a nonsteroidal anti-inflammatory drug (NSAID), to opioids for postoperative pain control. The study's main objective was to evaluate the noninferiority of ketorolac to opioids for managing pain after ureteroscopy. Their findings suggest that ketorolac can be a viable alternative to opioids for pain management, a welcome respite in the desert of postoperative pain.

A New Route: Ketorolac Shows Promise as a Non-Opioid Option

The study found that ketorolac was noninferior to opioids for managing pain after ureteroscopy, a significant finding like discovering a hidden well in the desert. This research offers a potential alternative to opioids, which are associated with risks like addiction and respiratory depression. This discovery has the potential to transform pain management practices, offering a safer and more effective approach, a path leading to a more comfortable recovery for patients.

Navigating the Landscape of Pain Management: Implications for Patient Care

The findings of this study offer a glimmer of hope in the vast desert of pain management, suggesting a potential alternative to opioids. The study's findings reinforce the importance of seeking safer and more effective pain management strategies, a journey that requires a collaborative effort between researchers, clinicians, and patients. This research could lead to a more comfortable and safe recovery for patients undergoing ureteroscopy.

Dr.Camel's Conclusion

This study is a welcome discovery in the desert of pain management, suggesting a potential alternative to opioids. The researchers have carved a new path, showing that ketorolac can effectively manage pain after ureteroscopy. This finding offers a glimmer of hope for patients seeking a safer and more comfortable recovery, a welcome oasis in the desert of post-operative pain.

Date :
  1. Date Completed 2021-07-26
  2. Date Revised 2022-01-07
Further Info :

Pubmed ID

33819072

DOI: Digital Object Identifier

10.1097/JU.0000000000001772

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.